Standard BioTools (LAB) Current Ratio: History & Chart

Standard BioTools Inc.(LAB)

Medical - Specialties · Boston, MA

$0.75-0.02 (-2.10%)

Delayed quote: Oct 6, 2026, 11:05 AM EDT

About Standard BioTools Inc.

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.

Boston, MA

387 employees

www.standardbio.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Michael Egholm

View full financials

LAB Current Ratio Metrics

CURRENT RATIO

9.10

CURRENT RATIO AVG TTM

7.04

CURRENT RATIO AVG 3Y

4.21

CURRENT RATIO AVG 5Y

3.81

CURRENT RATIO AVG 10Y

3.26

CURRENT RATIO AVG 15Y

3.95

CURRENT RATIO AVG 20Y

3.68

CURRENT VS TTM AVG

+29.30%

CURRENT VS 3Y AVG

+115.96%

CURRENT VS 5Y AVG

+138.56%

CURRENT VS 10Y AVG

+178.77%

CURRENT VS 15Y AVG

+130.39%

CURRENT VS 20Y AVG

+147.41%

SECTOR MEDIAN · HEALTHCARE

3.39

median of 645 covered companies

CURRENT VS SECTOR MEDIAN

+168.42%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Standard BioTools Inc. (LAB)	$292.42M	9.10	7.04	4.21	3.81
BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›	$293.99M	4.69	11.27	11.27	11.27
Larimar Therapeutics, Inc. (LRMR)vs ›	$290.35M	4.70	5.10	7.75	8.34
Abeona Therapeutics Inc. (ABEO)vs ›	$286.40M	6.63	6.50	6.00	4.95
Fulcrum Therapeutics, Inc. (FULC)vs ›	$283.44M	31.35	25.02	20.04	16.03
Benitec Biopharma Inc. (BNTC)vs ›	$304.97M	34.00	44.34	25.02	19.51
Aurora Cannabis Inc. (ACB)vs ›	$278.45M	5.36	5.13	3.92	3.90
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$310.71M	13.28	4.54	4.54	4.54
Indaptus Therapeutics, Inc. (INDP)vs ›	$275.74M	19.48	1.73	4.11	4.35
Fate Therapeutics, Inc. (FATE)vs ›	$275.66M	4.85	6.69	6.56	6.64

NAME

MARKET CAP

CURRENT RATIO

TTM

Standard BioTools Inc. (LAB)

$292.42M

9.10

7.04

4.21

3.81

BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›

$293.99M

4.69

11.27

Larimar Therapeutics, Inc. (LRMR)vs ›

$290.35M

4.70

5.10

7.75

8.34

Abeona Therapeutics Inc. (ABEO)vs ›

$286.40M

6.63

6.50

6.00

4.95

Fulcrum Therapeutics, Inc. (FULC)vs ›

$283.44M

31.35

25.02

20.04

16.03

Benitec Biopharma Inc. (BNTC)vs ›

$304.97M

34.00

44.34

25.02

19.51

Aurora Cannabis Inc. (ACB)vs ›

$278.45M

5.36

5.13

3.92

3.90

Mobia Medical, Inc. Common Stock (MOBI)vs ›

$310.71M

13.28

4.54

Indaptus Therapeutics, Inc. (INDP)vs ›

$275.74M

19.48

1.73

4.11

4.35

Fate Therapeutics, Inc. (FATE)vs ›

$275.66M

4.85

6.69

6.56

6.64

Current Ratio FAQ

What is the current ratio for Standard BioTools Inc. (LAB)?

The current ratio for LAB stock is 9.10.

Is Standard BioTools Inc.'s current ratio high or low?

The current ratio of 9.10 is 139% above its 5-year average of 3.81, near the high end of its 5-year range (1.45–12.36).

What is the TTM average current ratio for Standard BioTools Inc. (LAB)?

The TTM average current ratio for LAB stock is 7.04.

What is the 3Y average current ratio for Standard BioTools Inc. (LAB)?

The 3Y average current ratio for LAB stock is 4.21.

What is the 5Y average current ratio for Standard BioTools Inc. (LAB)?

The 5Y average current ratio for LAB stock is 3.81.

What is the 10Y average current ratio for Standard BioTools Inc. (LAB)?

The 10Y average current ratio for LAB stock is 3.26.

What is the 15Y average current ratio for Standard BioTools Inc. (LAB)?

The 15Y average current ratio for LAB stock is 3.95.

What is the 20Y average current ratio for Standard BioTools Inc. (LAB)?

The 20Y average current ratio for LAB stock is 3.68.

DATE	CURRENT RATIO
2026-06-30	9.10
2026-03-31	12.36
2025-12-31	4.19
2025-09-30	4.38
2025-06-30	5.16
2025-03-31	6.12
2024-12-31	5.70
2024-09-30	3.76
2024-06-30	3.88
2024-03-31	4.50
2023-12-31	1.45
2023-09-30	3.30
2023-06-30	3.91
2023-03-31	4.45
2022-12-31	4.81
2022-09-30	4.96
2022-06-30	5.87
2022-03-31	1.55
2021-12-31	1.45
2021-09-30	1.55
2021-06-30	1.48
2021-03-31	1.80
2020-12-31	2.17
2020-09-30	2.87
2020-06-30	2.05
2020-03-31	2.33
2019-12-31	2.93
2019-09-30	2.89
2019-06-30	2.86
2019-03-31	3.26
2018-12-31	3.38
2018-09-30	1.85
2018-06-30	2.05
2018-03-31	2.40
2017-12-31	2.83
2017-09-30	3.02
2017-06-30	2.31
2017-03-31	2.75
2016-12-31	3.28
2016-09-30	3.87
2016-06-30	3.93
2016-03-31	4.52
2015-12-31	4.79
2015-09-30	5.29
2015-06-30	4.96
2015-03-31	6.23
2014-12-31	5.31
2014-09-30	4.86
2014-06-30	4.67
2014-03-31	6.95
2013-12-31	6.06
2013-09-30	5.76
2013-06-30	6.93
2013-03-31	8.54
2012-12-31	8.73
2012-09-30	8.04
2012-06-30	3.77
2012-03-31	3.19
2011-12-31	3.47
2011-09-30	3.87
2011-06-30	4.56
2011-03-31	4.90
2010-12-31	1.13
2010-09-30	1.60
2010-06-30	0.00
2010-03-31	0.00
2009-12-31	4.00
2008-12-31	3.43
2008-06-30	2.82
2007-12-31	4.35

DATE

CURRENT RATIO

2026-06-30

9.10

2026-03-31

12.36

2025-12-31

4.19

2025-09-30

4.38

2025-06-30

5.16

2025-03-31

6.12

2024-12-31

5.70

2024-09-30

3.76

2024-06-30

3.88

2024-03-31

4.50

2023-12-31

1.45

2023-09-30

3.30

2023-06-30

3.91

2023-03-31

4.45

2022-12-31

4.81

2022-09-30

4.96

2022-06-30

5.87

2022-03-31

1.55

2021-12-31

1.45

2021-09-30

1.55

2021-06-30

1.48

2021-03-31

1.80

2020-12-31

2.17

2020-09-30

2.87

2020-06-30

2.05

2020-03-31

2.33

2019-12-31

2.93

2019-09-30

2.89

2019-06-30

2.86

2019-03-31

3.26

2018-12-31

3.38

2018-09-30

1.85

2018-06-30

2.05

2018-03-31

2.40

2017-12-31

2.83

2017-09-30

3.02

2017-06-30

2.31

2017-03-31

2.75

2016-12-31

3.28

2016-09-30

3.87

2016-06-30

3.93

2016-03-31

4.52

2015-12-31

4.79

2015-09-30

5.29

2015-06-30

4.96

2015-03-31

6.23

2014-12-31

5.31

2014-09-30

4.86

2014-06-30

4.67

2014-03-31

6.95

2013-12-31

6.06

2013-09-30

5.76

2013-06-30

6.93

2013-03-31

8.54

2012-12-31

8.73

2012-09-30

8.04

2012-06-30

3.77

2012-03-31

3.19

2011-12-31

3.47

2011-09-30

3.87

2011-06-30

4.56

2011-03-31

4.90

2010-12-31

1.13

2010-09-30

1.60

2010-06-30

0.00

2010-03-31

0.00

2009-12-31

4.00

2008-12-31

3.43

2008-06-30

2.82

2007-12-31

4.35

Current Ratio: 9.10

LAB Current Ratio

LAB Average Current Ratio Chart

LAB Current vs Average Current Ratio Chart

LAB Current Ratio Metrics

LAB Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

LAB Current Ratio History

Related Metrics